Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
EPIX ESSA Pharma Inc. daily Stock Chart
EPIX [NASD]
ESSA Pharma Inc.
Healthcare | Drug Manufacturers - Other | Canada
financial highlights | statements
Index- P/E- EPS (ttm)-2.12 Insider Own- Shs Outstand5.78M Perf Week-3.66%
Market Cap13.44M Forward P/E- EPS next Y- Insider Trans- Shs Float2.12M Perf Month-33.33%
Income- PEG- EPS next Q- Inst Own- Short Float0.36% Perf Quarter-39.88%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.74 Perf Half Y-40.39%
Book/sh1.07 P/B2.17 EPS next Y- ROA- Target Price- Perf Year-27.29%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.87 - 5.83 Perf YTD10.80%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-61.41% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low20.32% ATR0.27
Employees15 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)29.92 Volatility10.03% 9.87%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.12 Prev Close2.33
ShortableYes LT Debt/Eq- EarningsMay 13 AMC Payout- Avg Volume10.38K Price2.25
Recom- SMA20-21.77% SMA50-32.72% SMA200-30.70% Volume751 Change-3.30%
Apr-25-19 07:30AM  ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019 PR Newswire
Apr-17-19 07:30AM  ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting CNW Group
Apr-12-19 02:00AM  ESSA Pharma Grants Stock Options CNW Group
Mar-28-19 05:02PM  ESSA Pharma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019 PR Newswire
05:01PM  ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer PR Newswire
Mar-18-19 07:30AM  ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference CNW Group
Mar-14-19 07:30AM  ESSA Pharma to Attend the 31st Annual ROTH Conference PR Newswire
Feb-11-19 07:30AM  ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium CNW Group
Feb-07-19 05:05PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2018 PR Newswire
Dec-13-18 05:02PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2018 PR Newswire
Nov-14-18 07:35AM  Investor Expectations to Drive Momentum within Townsquare Media, Koss, ESSA Pharma, MVC Capital, Valeritas, and Sonic Foundry Discovering Underlying Factors of Influence GlobeNewswire
Oct-22-18 07:00AM  ESSA Appoints Otello Stampacchia, PH.D., of Omega Funds to Board of Directors PR Newswire
Aug-29-18 07:00AM  ESSA Pharma to Present at 20th Annual Global Investment Conference In New York City September 4 - 6, 2018 PR Newswire
Aug-14-18 07:00AM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018 CNW Group
May-14-18 07:15PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2018 CNW Group -5.16%
May-10-18 05:05PM  Essa Pharma Inc. Regains Compliance with NASDAQ Listing Requirements CNW Group
Apr-26-18 07:00AM  ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018 CNW Group
Apr-25-18 07:00AM  ESSA Pharma Inc. Announces Completion of Share Consolidation CNW Group
Apr-24-18 07:30AM  ESSA Pharma Enhances R&D Capabilities with Two New Key Hires CNW Group +8.12%
Apr-19-18 07:38PM  ESSA Pharma Inc. Announces Share Consolidation CNW Group +5.69%
Apr-12-18 09:51AM  Does ESSA Pharma Inc (CVE:EPI) Go Up With The Market? Simply Wall St.
Mar-28-18 09:56PM  ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders PR Newswire
Feb-23-18 09:02AM  ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants PR Newswire
09:02AM  ESSA Pharma Approves Stock Option Plan, RSU Plan, and Option Grants CNW Group
Feb-13-18 05:00PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 PR Newswire
05:00PM  ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2017 CNW Group
Jan-26-18 07:00AM  ESSA to Present at Noble Capital Markets' NobleCon14 PR Newswire
07:00AM  ESSA to Present at Noble Capital Markets' NobleCon14 CNW Group
Jan-25-18 11:00PM  ESSA Announces Management Team Change PR Newswire -6.33%
11:00PM  ESSA Announces Management Team Change CNW Group
Jan-16-18 09:40PM  ESSA expects 180-day extension to regain compliance with the Nasdaq Bid Price Rule CNW Group
08:40AM  ESSA Completes Second Tranche of Equity Offering, Raising Additional US$5 Million PR Newswire
Jan-09-18 08:43AM  ESSA Completes US$21 Million Equity Offering PR Newswire -9.72%
08:40AM  ESSA Completes US$21 Million Equity Offering CNW Group
Jan-05-18 06:30PM  ESSA Announces Filing of Second Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering PR Newswire +8.42%
06:30PM  ESSA announces filing of second amended and restated prospectus supplement and an update to previously announced equity offering CNW Group
Jan-02-18 07:45PM  ESSA Announces Filing of Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering CNW Group +8.53%
Dec-19-17 07:40AM  Wired News ESSA Announces Update on Previously Declared Equity Offering and Filing of Prospectus Supplement ACCESSWIRE -8.31%
Dec-15-17 10:52PM  ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering PR Newswire
10:42PM  ESSA Announces Filing of Prospectus Supplement and an Update to Previously Announced Equity Offering CNW Group
Dec-13-17 08:55AM  ESSA Pharma Announces Pricing of Previously Announced Equity Offering CNW Group
Dec-12-17 05:35PM  ESSA Pharma Announces Overnight Marketed Equity Offering CNW Group
Dec-11-17 09:21PM  ESSA Pharma Announces Financial Results for the Fiscal Fourth Quarter and Year Ended September 30, 2017 PR Newswire -8.97%
Nov-22-17 05:05PM  ESSA Pharma Announces New Listing on the TSX Venture Exchange Concurrent with Voluntary Delisting from the TSX PR Newswire
Sep-11-17 07:30AM  ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans PR Newswire -36.61%
07:30AM  ESSA Pharma Announces Results from the Phase 1 Clinical Trial of EPI-506 for Treatment of mCRPC and Updates Clinical and Strategic Plans CNW Group
Sep-07-17 07:30AM  ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress PR Newswire +37.50%
07:30AM  ESSA Pharma Announces Abstract Presentation on EPI-506 at the European Society for Medical Oncology 2017 Congress CNW Group
Sep-01-17 07:30AM  ESSA Pharma to Present at Rodman & Renshaw 19th Annual Global Investment Conference CNW Group
Aug-14-17 08:55PM  ESSA Pharma Provides Business Update and Announces Financial Results for the Fiscal Third Quarter Ended June 30, 2017 CNW Group
Jul-24-17 07:30AM  ESSA Pharma Provides Further Update on Proposed Equity Offering PR Newswire +41.71%
07:30AM  ESSA Pharma Provides Further Update on Proposed Equity Offering CNW Group
Jul-21-17 07:30AM  ESSA Pharma Announces Receipt of NASDAQ Notice of Market Value Deficiency CNW Group +24.20%
Jul-20-17 07:30AM  ESSA Pharma Announces Receipt of NASDAQ Notice of Bid Price Deficiency CNW Group -16.64%
Jul-18-17 08:07AM  ESSA Pharma Announces Update to Proposed Equity Offering PR Newswire
Jul-13-17 11:57AM  ESSA Pharma Announces Pricing of Proposed Equity Offering PR Newswire -28.00%
11:57AM  ESSA Pharma Announces Pricing Of Proposed Equity Offering CNW Group
Jul-12-17 04:10PM  ESSA Pharma Announces Overnight Marketed Equity Offering CNW Group
ESSA Pharma Inc., a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
open in yahoo | open in reuters | open in google